Observing the Real-World Application Effectiveness of Cytokine Immune Adsorption Technology in AIDS Patients with Severe Pneumonia or septic shock.
This is a prospective, single-center, non-randomized, clinical observational cohort study primarily focused on observing the clinical effects of cytokine adsorption technology in patients with AIDS complicated by severe pneumonia and/or septic shock. Based on the real-world application of cytokine adsorption technology in AIDS patients with severe pneumonia or septic shock, the study divides patients into two groups: one receiving cytokine adsorption combined with standard treatment, and another receiving standard treatment only. The study aims to observe the impact of these two different treatment strategies on clinical outcomes.
Study Type
OBSERVATIONAL
Enrollment
60
During treatment with cytokine adsorption cartridge, the patient's blood is passed through these cartridges, which contain substances that can adsorb specific cytokines. Excess cytokines are captured and removed by these substances, and then the cleansed blood is returned to the patient's body.
Guangzhou Eighth People's Hospital, Guangzhou Medical University
Guangzhou, Guangdong, China
RECRUITINGMortality rate
Compare the mortality rates of the cytokine adsorption combined with standard treatment group and the standard treatment group.
Time frame: 4 weeks
Improvement in critical care scoring
Improvements in the intensive care scoring systems SOFA score and APACHE II score from baseline and after intervention.
Time frame: Baseline and during treatment at weeks 1, 2, 3, 4.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.